Fundz

S3V Vascular Technologies Ltd raised a Series B funding round led by former L&T chairman Naik and Madhusudan Kela to fund a Rs 300-crore manufacturing facility for neurovascular devices in Mysore.

PRIVATEMar 14, 2024

Round Type

Series B

MysoreManufacturingHealth CareMedical

Investors

Madhusudan KelaA.M. Naik

Description

S3V Vascular Technologies Ltd received backing from former Larsen & Toubro chairman A.M. Naik and stock market investor Madhusudan Kela as part of a Series B funding round. The amount raised was not disclosed, but it will be used to fund the construction of a Rs 300-crore manufacturing facility for neurovascular devices in Mysore, as well as for the expansion into cardiology-related medical devices.

Quick answer

S3V Vascular Technologies Ltd raised an undisclosed amount in a Series B round, dated March 14, 2024. Investors: Madhusudan Kela and A.M. Naik. S3V Vascular Technologies Ltd is based in Mysore, Karnataka, India.

How much did S3V Vascular Technologies Ltd raise?
S3V Vascular Technologies Ltd raised an undisclosed amount in a Series B round on March 14, 2024.
Who invested in S3V Vascular Technologies Ltd?
Madhusudan Kela and A.M. Naik are named as investors in this round.
What does S3V Vascular Technologies Ltd do?
S3V Vascular Technologies aims to be a global leader in medical technology, working towards enhancing the lives of patients afflicted with cardiovascular diseases.
Where is S3V Vascular Technologies Ltd based and how big is it?
S3V Vascular Technologies Ltd is based in Mysore, Karnataka, India.
Who are the decision-makers at S3V Vascular Technologies Ltd?
Fundz holds 3 contacts at S3V Vascular Technologies Ltd. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Manufacturing around the same time

Companies in the same sectors as S3V Vascular Technologies Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Nami Surgical raised $123K (Pre-Seed) on April 22, 2024.
  • Neurovalens raised $2.7M (Seed) on April 8, 2024.
  • ViaLase raised $38M on March 25, 2024.
  • Third Pole raised $2.2M on March 18, 2024.
  • Biobot Surgical raised $18M (Series B) on March 7, 2024.
  • Tenon Medical raised $2.6M (Seed) on February 20, 2024.

Who to call at S3V Vascular Technologies Ltd, and when

A new round usually means S3V Vascular Technologies Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day S3V Vascular Technologies Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at S3V Vascular Technologies Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at S3V Vascular Technologies Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

S3V Vascular Technologies Ltd

Location

Mysore, Karnataka, India

About

S3V Vascular Technologies aims to be a global leader in medical technology, working towards enhancing the lives of patients afflicted with cardiovascular diseases. At S3V Vascular, we help healthcare professionals create a healthier world.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment S3V Vascular Technologies Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for S3V Vascular Technologies Ltd's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

S3V Vascular Technologies Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.